Business · 04/02/2020Updated: 10/17/2026 · 1 min read
FDA and FTC Host Public Workshop on Competitive Biosimilars Marketplace
Summary
The Food and Drug Administration and the Federal Trade Commission are hosting a public workshop on March 9, 2020, to discuss their efforts to promote the adoption of biosimilars and prevent false or misleading communications about them.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →